Treatment outcomes of combination versus monotherapy in Stenotrophomonas maltophilia bacteremia: a retrospective single-center analysis
Antimicrobial Agents and Chemotherapy · 03.06.2026 · 70 (6)
DOI: 10.1128/aac.01297-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 03.06.2026. Verfasst von Ming-Hang Tsai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious, Department of Medicine, Tri-Service General Hospital SongShan Branch, National Defense Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Stenotrophomonas maltophilia, Bacteremia, Gram-Negative Bacterial Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tri-Service General Hospital, National Defense Medical University.
Abstract (Originalsprache)
A combination therapy (CT) is recommended for S. maltophilia infections; however, supporting clinical data are limited. This study aimed to compare the effectiveness and safety of CT and monotherapy (MT) in the treatment of S. maltophilia bacteremia. A total of 292 adult inpatients with monomicrobial S. maltophilia bacteremia who received in vitro active CT or MT for >48 h were included for comparison. Multivariable logistic regression analysis was performed. The primary outcome was 30-day mortality, and the secondary outcomes included in-hospital mortality, microbiological eradication rate, clinical response, recurrent bacteremia, isolation of non-susceptible S. maltophilia isolates, and adverse drug reaction (ADR) occurrence. Thirty-seven patients received CT, and 255 received MT. Overall, the 30-day mortality was 24.0%, and patients treated with CT had lower 30-day mortality than those with MT (10.8% vs 25.9%; P = 0.045). The multivariable regression analysis revealed that CT was an independent protective factor. In addition, sensitivity analyses excluding patients with bacterial co-infections showed a consistent trend. Other outcomes were similar between the groups: in-hospital mortality (37.8% vs 36.9%, P = 0.909), clinical response (73.0% vs 71.8%, P = 0.879), microbiological eradication rate (94.6% vs 93.0%, P = 1.000), recurrent bacteremia (0% vs 9.4%, P = 0.087), non-susceptible S. maltophilia isolation (24.3% vs 14.9%, P = 0.145), and ADR occurrence (8.1% vs 13.7%, P = 0.441). CT for S. maltophilia bacteremia was associated with improved outcomes and comparable rates of ADRs and resistance emergence; however, randomized trials with larger cohorts are warranted to confirm these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious, Department of Medicine, Tri-Service General Hospital SongShan Branch, National Defense Medical University, Taipei, Taiwan.
- Division of Infectious Diseases, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan.
- Division of Infectious Diseases, Department of Internal Medicine, Zuoying Armed Forces General Hospital, Kaohsiung, Taiwan.
- Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.
- Department of Pathology, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
- Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
ORCID-Profile: L Kristopher Siu, Ching-Hsun Wang
Förderung
- Tri-Service General Hospital
- National Defense Medical University
Zitieren
APA
Tsai, M. H., Chen, W. P., Chen, C. L., Siu, L. K., Yu, C. M., Shang, H. S., Chang, F. Y., Lin, J. C., Yang, Y. S., & Wang, C. H. (2026). Treatment outcomes of combination versus monotherapy in Stenotrophomonas maltophilia bacteremia: a retrospective single-center analysis. Antimicrobial Agents and Chemotherapy, 70(6). https://doi.org/10.1128/aac.01297-25
Vancouver
Tsai MH, Chen WP, Chen CL, Siu LK, Yu CM, Shang HS, et al. Treatment outcomes of combination versus monotherapy in Stenotrophomonas maltophilia bacteremia: a retrospective single-center analysis. Antimicrobial Agents and Chemotherapy. 2026;70(6). doi:10.1128/aac.01297-25
BibTeX
@article{Tsai2026,
author = {Tsai, Ming-Hang and Chen, Wei-Ping and Chen, Chien-Liang and Siu, L Kristopher and Yu, Ching-Mei and Shang, Hung-Sheng and Chang, Feng-Yee and Lin, Jung-Chung and Yang, Ya-Sung and Wang, Ching-Hsun},
title = {Treatment outcomes of combination versus monotherapy in Stenotrophomonas maltophilia bacteremia: a retrospective single-center analysis},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
volume = {70},
number = {6},
doi = {10.1128/aac.01297-25}
}
EUVIMED